About Pneuma Respiratory
Pneuma Respiratory is a company based in Boone (United States) founded in 2015.. Pneuma Respiratory has raised $42 million across 7 funding rounds from investors including Haisco Pharmaceutical Group. Pneuma Respiratory offers products and services including Reduced-risk Nicotine Platform and Pharmaceutical Delivery Platform. Pneuma Respiratory operates in a competitive market with competitors including Aerami, Breath Therapeutics, Activaero, Beyond Air and Bespak, among others.
- Headquarter Boone, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pneuma Respiratory, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$42 M (USD)
in 7 rounds
-
Latest Funding Round
$3.3 M (USD), Series B
Feb 10, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pneuma Respiratory
Pneuma Respiratory offers a comprehensive portfolio of products and services, including Reduced-risk Nicotine Platform and Pharmaceutical Delivery Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-heated system for safer nicotine delivery to aid smoking cessation.
Aerosol technology for precise lung treatment of diseases like COPD.
Funding Insights of Pneuma Respiratory
Pneuma Respiratory has successfully raised a total of $42M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $3.3 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series B — $3.3M
-
First Round
First Round
(19 Jul 2018)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Series B - Pneuma Respiratory | Valuation |
investors |
|
| Nov, 2024 | Amount | Series B - Pneuma Respiratory | Valuation |
investors |
|
| Jun, 2023 | Amount | Series B - Pneuma Respiratory | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pneuma Respiratory
Pneuma Respiratory has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Haisco Pharmaceutical Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical products are developed for various therapeutic areas.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pneuma Respiratory
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pneuma Respiratory
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pneuma Respiratory Comparisons
Competitors of Pneuma Respiratory
Pneuma Respiratory operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aerami, Breath Therapeutics, Activaero, Beyond Air and Bespak, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for cardiopulmonary diseases are developed using inhaled therapies.
|
|
| domain | founded_year | HQ Location |
Inhalation therapies are developed for severe respiratory orphan diseases.
|
|
| domain | founded_year | HQ Location |
Controlled breathing technologies for inhaler devices were developed.
|
|
| domain | founded_year | HQ Location |
Developer of device for treating respiratory conditions
|
|
| domain | founded_year | HQ Location |
Respiratory drug delivery devices are developed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pneuma Respiratory
Frequently Asked Questions about Pneuma Respiratory
When was Pneuma Respiratory founded?
Pneuma Respiratory was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Where is Pneuma Respiratory located?
Pneuma Respiratory is headquartered in Boone, United States. It is registered at Boone, North Carolina, United States.
Who is the current CEO of Pneuma Respiratory?
Eric Hunter is the current CEO of Pneuma Respiratory.
Is Pneuma Respiratory a funded company?
Pneuma Respiratory is a funded company, having raised a total of $42M across 7 funding rounds to date. The company's 1st funding round was a Series B of $7.34M, raised on Jul 19, 2018.
What does Pneuma Respiratory do?
Pneuma Respiratory was founded in 2015 in Boone, United States, focusing on the medical device sector for respiratory care. Inhaled drug delivery systems are created, including the PNEUMAHALER, which integrates drug cartridges for inspiratory flow and AI-driven droplet ejection. Connectivity to a mobile app is provided for monitoring inspiration, offering coaching, feedback, and usage statistics to support patient adherence.
Who are the top competitors of Pneuma Respiratory?
Pneuma Respiratory's top competitors include Beyond Air, Aerami and Breath Therapeutics.
What products or services does Pneuma Respiratory offer?
Pneuma Respiratory offers Reduced-risk Nicotine Platform and Pharmaceutical Delivery Platform.
Who are Pneuma Respiratory's investors?
Pneuma Respiratory has 1 investor. Key investors include Haisco Pharmaceutical Group.